|
|
Article: GlaxoSmithKline's Rotavirus Vaccine Candidate Shown Effective Against Rotavirus Disease.
- Article from:
- PR Newswire
- Article date:
- January 4, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data Published in New England Journal of Medicine Establishes Safety Profile of New Rotavirus Vaccine Candidate
PHILADELPHIA, Jan. 4 /PRNewswire-FirstCall/ -- Data from one of the largest infant vaccine trials ever conducted, published today in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children. Every year, rotavirus is associated with an estimated 25 million clinic visits, two million hospitalizations and ...